Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Omid Cameron Farokhzad, M.D.

Co-Author

This page shows the publications co-authored by Omid Farokhzad and Jinjun Shi.
Connection Strength

7.927
  1. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017 01; 17(1):20-37.
    View in: PubMed
    Score: 0.705
  2. Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing. Nanomedicine. 2014 Jul; 10(5):897-900.
    View in: PubMed
    Score: 0.587
  3. Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery. Angew Chem Int Ed Engl. 2011 Jul 25; 50(31):7027-31.
    View in: PubMed
    Score: 0.485
  4. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc Chem Res. 2011 Oct 18; 44(10):1123-34.
    View in: PubMed
    Score: 0.485
  5. Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models. Sci Transl Med. 2021 06 23; 13(599).
    View in: PubMed
    Score: 0.243
  6. Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice. Biomaterials. 2021 01; 266:120431.
    View in: PubMed
    Score: 0.231
  7. siRNA nanoparticles targeting CaMKII? in lesional macrophages improve atherosclerotic plaque stability in mice. Sci Transl Med. 2020 07 22; 12(553).
    View in: PubMed
    Score: 0.228
  8. Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy. Nano Lett. 2020 07 08; 20(7):4857-4863.
    View in: PubMed
    Score: 0.226
  9. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition. Sci Transl Med. 2019 12 18; 11(523).
    View in: PubMed
    Score: 0.219
  10. Nanobuffering of pH-Responsive Polymers: A Known but Sometimes Overlooked Phenomenon and Its Biological Applications. ACS Nano. 2019 05 28; 13(5):4876-4882.
    View in: PubMed
    Score: 0.209
  11. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. Theranostics. 2018; 8(21):6008-6024.
    View in: PubMed
    Score: 0.203
  12. Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nat Biomed Eng. 2018 11; 2(11):850-864.
    View in: PubMed
    Score: 0.200
  13. Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy. Small. 2018 10; 14(41):e1802565.
    View in: PubMed
    Score: 0.200
  14. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr-/- Mice. Adv Healthc Mater. 2017 Oct; 6(20).
    View in: PubMed
    Score: 0.185
  15. Antimonene Quantum Dots: Synthesis and Application as Near-Infrared Photothermal Agents for Effective Cancer Therapy. Angew Chem Int Ed Engl. 2017 09 18; 56(39):11896-11900.
    View in: PubMed
    Score: 0.185
  16. ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy. . 2017 Sep; 29(33).
    View in: PubMed
    Score: 0.184
  17. Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy. . 2017 07 12; 17(7):4427-4435.
    View in: PubMed
    Score: 0.184
  18. Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo. Theranostics. 2017; 7(7):1990-2002.
    View in: PubMed
    Score: 0.183
  19. Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy. ACS Nano. 2017 03 28; 11(3):2618-2627.
    View in: PubMed
    Score: 0.180
  20. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer. Proc Natl Acad Sci U S A. 2016 07 12; 113(28):7750-5.
    View in: PubMed
    Score: 0.172
  21. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy. Angew Chem Int Ed Engl. 2016 06 13; 55(25):7091-7094.
    View in: PubMed
    Score: 0.170
  22. Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins. Angew Chem Int Ed Engl. 2016 Mar 01; 55(10):3309-12.
    View in: PubMed
    Score: 0.167
  23. Nanotechnology for protein delivery: Overview and perspectives. J Control Release. 2016 10 28; 240:24-37.
    View in: PubMed
    Score: 0.164
  24. Hydrophobic Cysteine Poly(disulfide)-based Redox-Hypersensitive Nanoparticle Platform for Cancer Theranostics. Angew Chem Int Ed Engl. 2015 Aug 03; 54(32):9218-23.
    View in: PubMed
    Score: 0.160
  25. Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment. Proc Natl Acad Sci U S A. 2015 Jun 23; 112(25):7779-84.
    View in: PubMed
    Score: 0.160
  26. A solvent-free thermosponge nanoparticle platform for efficient delivery of labile proteins. Nano Lett. 2014 Nov 12; 14(11):6449-55.
    View in: PubMed
    Score: 0.153
  27. Development of multinuclear polymeric nanoparticles as robust protein nanocarriers. Angew Chem Int Ed Engl. 2014 Aug 18; 53(34):8975-9.
    View in: PubMed
    Score: 0.150
  28. Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release. 2014 Sep 28; 190:485-99.
    View in: PubMed
    Score: 0.150
  29. Development of therapeutic polymeric nanoparticles for the resolution of inflammation. Adv Healthc Mater. 2014 Sep; 3(9):1448-1456.
    View in: PubMed
    Score: 0.147
  30. Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug. Proc Natl Acad Sci U S A. 2013 Nov 12; 110(46):18638-43.
    View in: PubMed
    Score: 0.143
  31. DNA self-assembly of targeted near-infrared-responsive gold nanoparticles for cancer thermo-chemotherapy. Angew Chem Int Ed Engl. 2012 Nov 19; 51(47):11853-7.
    View in: PubMed
    Score: 0.133
  32. Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano. 2012 Jan 24; 6(1):696-704.
    View in: PubMed
    Score: 0.126
  33. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett. 2010 Sep 08; 10(9):3223-30.
    View in: PubMed
    Score: 0.115
  34. Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. Nanomedicine (Lond). 2010 Feb; 5(2):269-85.
    View in: PubMed
    Score: 0.110
  35. Progress in siRNA delivery using multifunctional nanoparticles. Methods Mol Biol. 2010; 629:53-67.
    View in: PubMed
    Score: 0.110
  36. Targeted delivery of Protein Arginine Deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity. Cardiovasc Res. 2021 Mar 05.
    View in: PubMed
    Score: 0.059
  37. Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination. Nano Lett. 2020 03 11; 20(3):1499-1509.
    View in: PubMed
    Score: 0.055
  38. Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance. . 2018 07 11; 18(7):4618-4625.
    View in: PubMed
    Score: 0.049
  39. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science. 2015 Jun 19; 348(6241):aaa8205.
    View in: PubMed
    Score: 0.040
  40. Engineered nanomedicine for myeloma and bone microenvironment targeting. Proc Natl Acad Sci U S A. 2014 Jul 15; 111(28):10287-92.
    View in: PubMed
    Score: 0.037
  41. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine. 2014 May 19; 32(24):2882-95.
    View in: PubMed
    Score: 0.037
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.